隴神戎發(300534.SZ):上半年業績由盈轉虧 預虧900萬元-1100萬元
格隆匯 7 月 17日丨隴神戎發(300534.SZ)公佈,預計上半年虧損:900萬元—1100萬元,上年同期盈利:844.62萬元。
1.報告期,受新型冠狀病毒肺炎疫情影響,公司藥品銷售,尤其是對終端醫療機構的藥品銷售影響較大,2020年上半年營業收入較上年同期下降13.55%,產量下降37.06%,固定性成本費用較大,影響公司經營出現虧損。
2.報告期內,非經常性損益對淨利潤的影響金額預計為64萬元。
3.報告期內,公司認真做好新型冠狀病毒肺炎疫情防控,全面落實甘肅省疫情防控物資採購、儲備、供應等相關工作任務,積極組織復工復產,壓實任務指標,制定營銷措施方案,積極化解新型冠狀病毒肺炎疫情對市場銷售帶來的不利影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.